Therapeutic Solutions International Announces Clinical Proof of Concept of Nanoparticle Pterostilbene Formulation: NanoStilbene™
02 juil. 2018 09h17 HE
|
Therapeutic Solutions International, Inc.
Early Clinical Trial Data Supports Enhanced Biodistribution of NanoStilbene™ Compared to Standard Pterostilbene When Orally Administered OCEANSIDE, Calif., July 02, 2018 (GLOBE NEWSWIRE) --...